UnknownNot Applicable

Hemodynamically Important Patent Ductus Arteriosus in Newborns Under 32 Weeks

Turkey (Türkiye)70 participantsStarted 2022-07-01

Plain-language summary

To define the characteristics of hemodynamically significant PDA by echocardiography, to investigate the systemic effects of the ductus with cerebral and renal Doppler flow studies, and to determine the oxygen consumption in the cerebral tissue with NIRS in newborns below 32 weeks of age with PDA.

Who can participate

Age range1 Minute – 7 Days

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Born at less than 32 weeks newborns Exclusion Criteria: * Congenital heart disease * Syndromic and/or major congenital anomaly

What they're measuring

Diameter of PDA

Timeframe: 1 year

Velosity of PDA

Timeframe: 1 year

Left ventricule expansion

Timeframe: 1 year

Velocity of internal carotid arteries, middle carotid arteries, anterior cerebral arteries and renal arteries

Timeframe: 1 year

Trial details

NCT IDNCT05686343

SponsorAnkara University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-07-01

Contact for this trial

Özlem Bayram

05058192105 drbayram.ozlem@gmail.com

View on ClinicalTrials.gov More Patent Ductus Arteriosus After Premature Birth trials